| Literature DB >> 35743807 |
Gayatri Sharma1, Patrick D Curtis1.
Abstract
The inside of a space-faring vehicle provides a set of conditions unlike anything experienced by bacteria on Earth. The low-shear, diffusion-limited microenvironment with accompanying high levels of ionizing radiation create high stress in bacterial cells, and results in many physiological adaptations. This review gives an overview of the effect spaceflight in general, and real or simulated microgravity in particular, has on primary and secondary metabolism. Some broad trends in primary metabolic responses can be identified. These include increases in carbohydrate metabolism, changes in carbon substrate utilization range, and changes in amino acid metabolism that reflect increased oxidative stress. However, another important trend is that there is no universal bacterial response to microgravity, as different bacteria often have contradictory responses to the same stress. This is exemplified in many of the observed secondary metabolite responses where secondary metabolites may have increased, decreased, or unchanged production in microgravity. Different secondary metabolites in the same organism can even show drastically different production responses. Microgravity can also impact the production profile and localization of secondary metabolites. The inconsistency of bacterial responses to real or simulated microgravity underscores the importance of further research in this area to better understand how microbes can impact the people and systems aboard spacecraft.Entities:
Keywords: microgravity; primary metabolism; radiation; secondary metabolism; spaceflight
Year: 2022 PMID: 35743807 PMCID: PMC9225508 DOI: 10.3390/life12060774
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Secondary Metabolites Production to Simulated Microgravity and Spaceflight.
| Organism | Metabolite | Impact of Microgravity | Experimental Location | References |
|---|---|---|---|---|
| Gramicidin S | Unchanged production level | Simulated microgravity | [ | |
| Microcin B17 | Decreased production with extracellular accumulation | Simulated microgravity (High-aspect rotating vessels (HARV)) | [ | |
| Microcin B17 | Increased production with shear stress (teflon bead) | Simulated microgravity (Rotating-wall bioreactors (RWV)) | [ | |
| β-lactam antibiotics | Decreased production | Simulated microgravity | [ | |
| Nikkomycin, Nikkomycin X, Z | Increased by 13–18 % | Space flight (15 days) | [ | |
| Rapamycin | Decreased production with extracellular accumulation site | Simulated microgravity (Rotating-wall bioreactor (RWB)) | [ | |
| Actinomycin D | Increased production with altered time course | US Space Shuttle mission STS-80 | [ | |
| Actinomycin D | Increased concentration at day 8 and 12 with decrease after | International space station (ISS) | [ | |
| Undecylprodigiosin (RED) | Unchanged production amount, earlier production time | 2D-clinostat | [ | |
| Actinorhodin (ACT) | Decreased production | 2D-clinostat | [ | |
| Undecylprodigiosin (RED) | Decreased production | Shenzhou-8 Space mission | [ | |
| Actinorhodin (ACT) | Decreased production | Shenzhou-8 Space mission | [ | |
| Poly-β-hydroxybutyrate (PHB) | Increased production at 24 h and decrease after 48 h | Simulated microgravity (Rotating wall vessel (RWV)) | [ | |
| Microcystin | Increased production with extracellular accumulation | Simulated microgravity (Rotary cell culture system (RCCS)) | [ |